# The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.

> **NCT04691323** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Ann & Robert H Lurie Children's Hospital of Chicago** · enrollment: 68 (actual)

## Conditions studied

- Sickle Cell Disease
- Sickle B+ Thalassemia
- Sickle Beta Zero Thalassemia
- Sickle Cell Hemoglobin C

## Interventions

- **OTHER:** HU-Go app

## Key facts

- **NCT ID:** NCT04691323
- **Lead sponsor:** Ann & Robert H Lurie Children's Hospital of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-02
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2024-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04691323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04691323, "The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04691323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*